← Leaderboards
Mark Esposito
Princeton University
$818,371
Attributed
$818,371
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $735.6K · FY2015–23$1M$750K$500K$250K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$818,371 · 3
By mechanism
R43$735,649 · 2
F31$82,722 · 1
Top collaborators
No co-investigators on record.
Most similar at Princeton University
Same institution · by research overlap
- Mohammad R Seyedsayamdost$8,154,584
- Sarah Jane Flint$4,192,845
Others in their field
Top investigators on “Series”
- Lawrence Corey · Fred Hutchinson Cancer Center$445,660,381
- Kiran Datta · Leidos Biomedical Research, Inc.$292,634,066
- David R. Weir · University Of Michigan At Ann Arbor$276,156,779
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$231,733,045
- Dennis R. Burton · Scripps Research Institute$199,946,411
- Joel A Lipkin · Four Points Technology, Llc$183,862,844
Research focus
SeriesIn VivoEnzymesCellsLigandsPathway InteractionsLeadProteinsNeoplasm MetastasisSignal PathwayMouse ModelNeoplastic CellInterestReceptorMalignant Breast NeoplasmDisseminated Malignant NeoplasmAntibodiesCancer PatientGenerationsImmuneAffectFutureMalignant NeoplasmsTissues
Grant awards (4)
Development of first-in-class antagonists of the retinoid pathway as novel oral immunotherapies for solid cancers$398,040
R43 · FY2023 · CA · contact PI
Development of first-in-class antagonists of the retinoid pathway as novel oral therapies for Type 2 Diabetes$337,609
R43 · FY2023 · DK · contact PI
Exploration of the dynamics of E-selectin interaction in breast cancer metastasis$39,602
F31 · FY2016 · CA · contact PI
Exploration of the dynamics of E-selectin interaction in breast cancer metastasis$43,120
F31 · FY2015 · CA · contact PI